Selective Targeting of Adjuvant Therapy for Endometrial Cancer: The STATEC Trial

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1080706

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This international collaborative trial for women with aggressive endometrial cancer will investigate whether lymph node removal (lymphadenectomy) at time of hysterectomy is needed to predict whether patients need additional treatment, compared to not removing the lymph nodes and giving additional treatment to all such patients. If we can select patients who need further treatment more accurately, we will avoid giving patients unnecessary toxic treatment which impacts on their quality of life.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2021

Funding Scheme: Project Grants

Funding Amount: $1,239,309.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

clinical trial | endometrial cancer | health economics | lymphoedema | surgery

Related Links